198 related articles for article (PubMed ID: 24266862)
21. A trisubstituted benzimidazole cell division inhibitor with efficacy against Mycobacterium tuberculosis.
Knudson SE; Awasthi D; Kumar K; Carreau A; Goullieux L; Lagrange S; Vermet H; Ojima I; Slayden RA
PLoS One; 2014; 9(4):e93953. PubMed ID: 24736743
[TBL] [Abstract][Full Text] [Related]
22. Cell division inhibitors with efficacy equivalent to isoniazid in the acute murine Mycobacterium tuberculosis infection model.
Knudson SE; Awasthi D; Kumar K; Carreau A; Goullieux L; Lagrange S; Vermet H; Ojima I; Slayden RA
J Antimicrob Chemother; 2015 Nov; 70(11):3070-3. PubMed ID: 26245639
[TBL] [Abstract][Full Text] [Related]
23. FtsZ inhibitors as a new genera of antibacterial agents.
Tripathy S; Sahu SK
Bioorg Chem; 2019 Oct; 91():103169. PubMed ID: 31398602
[TBL] [Abstract][Full Text] [Related]
24. BT-benzo-29 inhibits bacterial cell proliferation by perturbing FtsZ assembly.
Ray S; Jindal B; Kunal K; Surolia A; Panda D
FEBS J; 2015 Oct; 282(20):4015-33. PubMed ID: 26258635
[TBL] [Abstract][Full Text] [Related]
25. Preliminary SAR and biological evaluation of antitubercular triazolothiadiazine derivatives against drug-susceptible and drug-resistant Mtb strains.
Li Z; Bai X; Deng Q; Zhang G; Zhou L; Liu Y; Wang J; Wang Y
Bioorg Med Chem; 2017 Jan; 25(1):213-220. PubMed ID: 27810439
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic potential of FtsZ inhibition: a patent perspective.
Awasthi D; Kumar K; Ojima I
Expert Opin Ther Pat; 2011 May; 21(5):657-79. PubMed ID: 21413908
[TBL] [Abstract][Full Text] [Related]
27. Pharmacophore based approach to screen and evaluate novel Mycobacterium cell division inhibitors targeting FtsZ - A modelling and experimental study.
Mitra K; Chadha A; Doble M
Eur J Pharm Sci; 2019 Jul; 135():103-112. PubMed ID: 31034983
[TBL] [Abstract][Full Text] [Related]
28. The structure, function, and regulation of Mycobacterium FtsZ.
Hong W; Deng W; Xie J
Cell Biochem Biophys; 2013 Mar; 65(2):97-105. PubMed ID: 22932926
[TBL] [Abstract][Full Text] [Related]
29. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
[TBL] [Abstract][Full Text] [Related]
30. Targeting cell division: small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality.
Margalit DN; Romberg L; Mets RB; Hebert AM; Mitchison TJ; Kirschner MW; RayChaudhuri D
Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11821-6. PubMed ID: 15289600
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, screening and docking analysis of novel benzimidazolium compounds as potent anti microbial agents targeting FtsZ protein.
Sangeeta GPV; Purna Nagasree K; Risy Namratha J; Krishna Kumar MM
Microb Pathog; 2018 Nov; 124():258-265. PubMed ID: 30149132
[TBL] [Abstract][Full Text] [Related]
32. In vitro-in vivo activity relationship of substituted benzimidazole cell division inhibitors with activity against Mycobacterium tuberculosis.
Knudson SE; Kumar K; Awasthi D; Ojima I; Slayden RA
Tuberculosis (Edinb); 2014 May; 94(3):271-6. PubMed ID: 24746463
[TBL] [Abstract][Full Text] [Related]
33. MoS
Raghu MS; Pradeep Kumar CB; Prasad KNN; Prashanth MK; Kumarswamy YK; Chandrasekhar S; Veeresh B
ACS Comb Sci; 2020 Oct; 22(10):509-518. PubMed ID: 32806898
[TBL] [Abstract][Full Text] [Related]
34. Rational design of berberine-based FtsZ inhibitors with broad-spectrum antibacterial activity.
Sun N; Chan FY; Lu YJ; Neves MA; Lui HK; Wang Y; Chow KY; Chan KF; Yan SC; Leung YC; Abagyan R; Chan TH; Wong KY
PLoS One; 2014; 9(5):e97514. PubMed ID: 24824618
[TBL] [Abstract][Full Text] [Related]
35. 1H-Benzo[d]imidazoles and 3,4-dihydroquinazolin-4-ones: Design, synthesis and antitubercular activity.
Macchi FS; Pissinate K; Villela AD; Abbadi BL; Rodrigues-Junior V; Nabinger DD; Altenhofen S; Sperotto N; da Silva Dadda A; Subtil FT; de Freitas TF; Erhart Rauber AP; Borsoi AF; Bonan CD; Bizarro CV; Basso LA; Santos DS; Machado P
Eur J Med Chem; 2018 Jul; 155():153-164. PubMed ID: 29885576
[TBL] [Abstract][Full Text] [Related]
36. 2-Alkoxycarbonylaminopyridines: inhibitors of Mycobacterium tuberculosis FtsZ.
White EL; Suling WJ; Ross LJ; Seitz LE; Reynolds RC
J Antimicrob Chemother; 2002 Jul; 50(1):111-4. PubMed ID: 12096015
[TBL] [Abstract][Full Text] [Related]
37. Identification of Mycobacterium tuberculosis CtpF as a target for designing new antituberculous compounds.
Santos P; Lopez-Vallejo F; Ramírez D; Caballero J; Mata Espinosa D; Hernández-Pando R; Soto CY
Bioorg Med Chem; 2020 Feb; 28(3):115256. PubMed ID: 31879181
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory activity of traditional plants against Mycobacterium smegmatis and their action on Filamenting temperature sensitive mutant Z (FtsZ)-A cell division protein.
Ravindran R; Chakrapani G; Mitra K; Doble M
PLoS One; 2020; 15(5):e0232482. PubMed ID: 32357366
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and evaluation of novel 9-arylalkyl-10-methylacridinium derivatives as highly potent FtsZ-targeting antibacterial agents.
Song D; Zhang N; Zhang P; Zhang N; Chen W; Zhang L; Guo T; Gu X; Ma S
Eur J Med Chem; 2021 Oct; 221():113480. PubMed ID: 33964649
[TBL] [Abstract][Full Text] [Related]
40. Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ.
Haranahalli K; Tong S; Ojima I
Bioorg Med Chem; 2016 Dec; 24(24):6354-6369. PubMed ID: 27189886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
